0001209191-13-056980.txt : 20131213
0001209191-13-056980.hdr.sgml : 20131213
20131213200308
ACCESSION NUMBER: 0001209191-13-056980
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131212
FILED AS OF DATE: 20131213
DATE AS OF CHANGE: 20131213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDO DALE G
CENTRAL INDEX KEY: 0001202278
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 131277515
MAIL ADDRESS:
STREET 1: C/O CELL GENESYS INC
STREET 2: 500 FORBES BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-12-12
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001202278
ANDO DALE G
C/O SANGAMO BIOSCIENCES INC.
POINT RICHMOND TECH CNTR, 501 CANAL BLVD
RICHMOND
CA
94804
0
1
0
0
VP, Therapeutic Dev. & CMO
Common Stock
2013-12-12
4
A
0
23000
0.00
A
111798
D
Common Stock
2013-12-12
4
F
0
14783
12.12
D
97015
D
Employee Stock Option (Right to Buy)
12.12
2013-12-12
4
A
0
46000
0.00
A
2023-12-11
Common Stock
46000
46000
D
Shares subject to restricted stock units ("RSUs"), which will vest in a series of three successive equal annual installments upon the Reporting Person's completion of each year of service over the three year period from the grant date.
Includes 33,333 shares and 23,333 shares subject to RSUs granted on December 8, 2011 and December 6, 2012, respectively, which will be issued as such units vest in accordance with their terms.
Represents shares withheld to satisfy the Reporting Person's tax withholding obligation upon the vesting and issuance of RSUs.
The stock option vests and becomes exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from the grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter.
/s/ Florence Tam, attorney-in-fact
2013-12-13